CLINICAL_TRIALS
trial_result
· 2009-11-19
Clinical Trial Update: MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED) [Phase 3]
Summary
A Phase 3 trial of maraviroc (MK0518) in HIV-infected patients switched from a protease inhibitor regimen was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infection | Phase 3 | Status: TERMINATED | Results posted: 2009-11-19